img
img
Immediate sequential bilateral cataract surgery is a reasonable and safe option during a pandemic     
Yazarlar (6)
Dr. Öğr. Üyesi Berire Şeyma DURMUŞ ECE Dr. Öğr. Üyesi Berire Şeyma DURMUŞ ECE
Kastamonu Üniversitesi, Türkiye
Armağan Özgür
Mehmed Uğur Işık
Türkiye
Utku Furuncuoğlu
Serdar İlgüy
Erdem Yüksel
Gazi Üniversitesi, Türkiye
Devamını Göster
Özet
To evaluate the preoperative and intraoperative features, intraoperative and postoperative complications and postoperative satisfaction of patients who underwent immediate sequential bilateral cataract surgery (ISBCS) during the COVID-19 pandemic. The study included ISBCS patients from September 2021 through January 2022. Demographics, comorbidities, type of anesthesia (topical/general), intraoperative complications, postoperative refractive errors, and complications were examined. The one-month postoperative appointment included a patient satisfaction questionnaire. ISBCS was performed in 206 eyes of 103 patients. Intraoperative complications did not occur in 99 (96.1%) of ISBCS patients. No patients had visually significant corneal edema, wound leakage, endophthalmitis, or toxic anterior segment syndrome during postoperative follow-up. Final manifest spherical equivalent refraction was less than 1.00 D in all patients and less than 0.50 D in 70.7% of patients. In the questionnaire given to the patients at the one-month follow-up, 96.1% of patients did not change their preference for surgery on the same day. ISBCS provides an advantage during the pandemic period by reducing hospital visits, especially for the elderly population and patients with comorbidities. ISBCS is a safe and reasonable method that can be used during a pandemic due to the low rates of complications, the success of the refractive results, and the high patient satisfaction rates.
Anahtar Kelimeler
Immediate sequential bilateral cataract surgery | COVID-19 pandemic | Simultaneous bilateral cataract surgery | Cataract
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale
Dergi Adı Journal Français d'Ophtalmologie
Dergi ISSN 0181-5512
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q3
Makale Dili İngilizce
Basım Tarihi 09-2023
Cilt No 46
Sayı 7
Sayfalar 742 / 749
Doi Numarası 10.1016/j.jfo.2022.12.028
Makale Linki http://dx.doi.org/10.1016/j.jfo.2022.12.028